Nissen Ni
About
In The Last Decade
Nissen Ni
36 papers receiving 384 citations
Peers
Comparison fields: 5 of 105
- Oncology 134
- Molecular Biology 122
- Pathology and Forensic Medicine 99
- Pulmonary and Respiratory Medicine 58
- Cardiology and Cardiovascular Medicine 50
Countries citing papers authored by Nissen Ni
This map shows the geographic impact of Nissen Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nissen Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nissen Ni more than expected).
Fields of papers citing papers by Nissen Ni
This network shows the impact of papers produced by Nissen Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nissen Ni. The network helps show where Nissen Ni may publish in the future.
Co-authorship network of co-authors of Nissen Ni
This figure shows the co-authorship network connecting the top 25 collaborators of Nissen Ni. A scholar is included among the top collaborators of Nissen Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nissen Ni. Nissen Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark. | 4 |
| 2 | Micropore filters for sterile filtration may leach toxic compounds affecting cell cultures (HL 60). | 9 |
| 3 | [Serious side-effects following treatment with mistletoe extract]. | 2 |
| 4 | [Phase-II-study with cis-diamminedichloroplatinum (II) in the treatment of advanced malignant lymphomas]. | 2 |
| 5 | Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results. | 8 |
| 6 | Phase I trial of a new form of an oral administration of VP-16-213. | 20 |
| 7 | Clinical trial of rubidazone in solid tumors and malignant lymphomas. | 2 |
| 8 | [Thyroid function in malignant lymphoma]. | 1 |
| 9 | Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B. | 12 |
| 10 | Adriamycin, an antitumour antibiotic: a review with special reference to daunomycin. | 42 |
| 11 | [Bone marrow biopsy with Radner's needle. A new method for bone marrow examination]. | 2 |
| 12 | Clinical trial with mycophenolic acid (NSC-129185), a new antitumor agent. | 11 |
| 13 | Studies on the antineoplastic effect of vanadium salts. | 14 |
| 14 | HOME OR AWAY? | 29 |
| 15 | [Effects of triiodothyropropionic acid (triopron) in hypercholesterolemia]. | 1 |
| 16 | [Spirolactonest a new diuretic principles. A short survey]. | 2 |
| 17 | [Use & abuse of phenacetin in Denmark]. | 4 |
| 18 | [Diabetes mellitus without glycosuria partial or hidden diabetes in potential diabetics]. | 1 |
| 19 | [Arterenol therapy of shock in coronary thrombosis; review and case report]. | 0 |
| 20 | [Erythromyelosis (Gulielmo's disease); review and report on case in a benzene worker]. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.